Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals

MLA

Federica Vernuccio, et al. “Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals.” Diagnostics, vol. 12, no. 5, May 2022, p. 1187. EBSCOhost, https://doi.org/10.3390/diagnostics12051187.

APA

Federica Vernuccio, Roberto Cannella, Giuseppe Cabibbo, Silvia Greco, Ciro Celsa, Francesco Matteini, Paolo Giuffrida, Massimo Midiri, Vito Di Marco, Calogero Cammà, & Giuseppe Brancatelli. (2022). Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals. Diagnostics, 12(5), 1187. https://doi.org/10.3390/diagnostics12051187

Chicago

Federica Vernuccio, Roberto Cannella, Giuseppe Cabibbo, Silvia Greco, Ciro Celsa, Francesco Matteini, Paolo Giuffrida, et al. 2022. “Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals.” Diagnostics 12 (5): 1187. doi:10.3390/diagnostics12051187.